Tg Therapeutics (TGTX) Operating Expenses (2011 - 2026)
Tg Therapeutics (TGTX) posted quarterly Operating Expenses of $170.1 million for Q1 2026, up 51.58% year-over-year from $112.2 million in Q1 2025, and up 19.74% quarter-over-quarter from $142.1 million in Q4 2025.
Tg Therapeutics (TGTX) Operating Expenses (2011 - 2026) Analysis & Trends
Tg Therapeutics' Operating Expenses history runs 16 years deep, the most recent figure standing at $170.1 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 51.58% year-over-year to $170.1 million; the TTM figure through Mar 2026 stood at $550.9 million (up 68.68% YoY), while the FY2025 annual figure was $493.0 million, up 71.72% from the prior year.
- Operating Expenses for Q1 2026 stood at $170.1 million, up from $142.1 million in the prior quarter.
- The five-year high for Operating Expenses was $170.1 million in Q1 2026, with the low at $35.1 million in Q3 2022.
- The 5-year median for Operating Expenses is $71.4 million (2024), against an average of $81.4 million.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses plunged 59.78% in 2022, then jumped 85.24% in 2025.
- Tg Therapeutics' Operating Expenses stood at $77.6 million in 2022, then decreased by 27.27% to $56.5 million in 2023, then jumped by 38.58% to $78.2 million in 2024, then soared by 81.6% to $142.1 million in 2025, then climbed by 19.74% to $170.1 million in 2026.
- Business Quant data shows TGTX's Operating Expenses at $170.1 million in Q1 2026, $142.1 million in Q4 2025, and $132.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 218.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 218.66 Mn |
| Mar 31, 2026 | 170.12 Mn |
| Dec 31, 2025 | 142.08 Mn |
| Sep 30, 2025 | 132.34 Mn |
| Jun 30, 2025 | 106.31 Mn |
| Mar 31, 2025 | 112.23 Mn |
| Dec 31, 2024 | 78.24 Mn |
| Sep 30, 2024 | 71.45 Mn |
| Jun 30, 2024 | 64.65 Mn |
| Mar 31, 2024 | 72.74 Mn |
| Dec 31, 2023 | 56.46 Mn |
| Sep 30, 2023 | 51.03 Mn |
| Jun 30, 2023 | 60.75 Mn |
| Mar 31, 2023 | 44.80 Mn |
| Dec 31, 2022 | 77.62 Mn |
| Sep 30, 2022 | 35.06 Mn |
| Jun 30, 2022 | 39.54 Mn |
| Mar 31, 2022 | 68.89 Mn |
| Dec 31, 2021 | 95.27 Mn |
| Sep 30, 2021 | 87.16 Mn |